Abstract
Critical illness is a pathophysiological stress response that typically requires mechanical ventilation and hemodynamic support in an intensive care unit (ICU). Allostatic mechanisms tailor the critically ill state and eventually downregulate the stress response. Failure to downregulate the stress response can lead to increased morbidity and mortality. In general, ICU care focuses on component organ system physiology and prioritizes cardiopulmonary function. However, vast knowledge gaps exist in understanding why some patients simply fail to recover from a prolonged critical illness condition. In this review, we present an integrative physiology approach to the metabolic care in critical illness with an emphasis on skeletal allostasis. In particular, we discuss the different allostatic responses and their effects on bone in acute, prolonged, and chronic critical illness, currently available clinical interventions targeting skeletal remodeling, and emergent biological therapies with skeletal effects. It is hoped that by shifting the paradigm to a systems approach, some of the significant knowledge gaps can be closed and critical illness outcomes can be improved.
Keywords: Critical illness, metabolic bone disease, integrative physiology, allostasis, biological therapies
Current Drug Therapy
Title: Pharmacological and Biological Therapies for Metabolic Bone Disease in Critical Illness: An Integrative Physiology Approach
Volume: 5 Issue: 1
Author(s): Aaron J. Weiss, Mone Zaidi and Jeffrey I. Mechanick
Affiliation:
Keywords: Critical illness, metabolic bone disease, integrative physiology, allostasis, biological therapies
Abstract: Critical illness is a pathophysiological stress response that typically requires mechanical ventilation and hemodynamic support in an intensive care unit (ICU). Allostatic mechanisms tailor the critically ill state and eventually downregulate the stress response. Failure to downregulate the stress response can lead to increased morbidity and mortality. In general, ICU care focuses on component organ system physiology and prioritizes cardiopulmonary function. However, vast knowledge gaps exist in understanding why some patients simply fail to recover from a prolonged critical illness condition. In this review, we present an integrative physiology approach to the metabolic care in critical illness with an emphasis on skeletal allostasis. In particular, we discuss the different allostatic responses and their effects on bone in acute, prolonged, and chronic critical illness, currently available clinical interventions targeting skeletal remodeling, and emergent biological therapies with skeletal effects. It is hoped that by shifting the paradigm to a systems approach, some of the significant knowledge gaps can be closed and critical illness outcomes can be improved.
Export Options
About this article
Cite this article as:
Weiss J. Aaron, Zaidi Mone and Mechanick I. Jeffrey, Pharmacological and Biological Therapies for Metabolic Bone Disease in Critical Illness: An Integrative Physiology Approach, Current Drug Therapy 2010; 5 (1) . https://dx.doi.org/10.2174/1574885511005010048
DOI https://dx.doi.org/10.2174/1574885511005010048 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
Current Medicinal Chemistry Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis
Current Stem Cell Research & Therapy Emerging Therapy Options in Heparin-Induced Thrombocytopenia
Cardiovascular & Hematological Agents in Medicinal Chemistry Obstructive Sleep Apnea and Atrial Arrhythmogenesis
Current Cardiology Reviews Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals Diabetes-induced Epigenetic Signature in Vascular Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Stroke Subtypes and their Possible Implication in Stroke Prevention Drug Strategies
Current Vascular Pharmacology Progression of Retinopathy in Type 1 Diabetic Women During Pregnancy
Current Diabetes Reviews Cellular Mechanisms for Diastolic Dysfunction in the Human Heart
Current Pharmaceutical Biotechnology Angiotensin II Type I Receptor Blocker and Endothelial Function in Humans: Role of Nitric Oxide and Oxidative Stress
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Mitochondrial MMP Activation, Dysfunction and Arrhythmogenesis in Hyperhomocysteinemia
Current Vascular Pharmacology Anthracyclines Still Prove Effective in Anticancer Therapy
Mini-Reviews in Medicinal Chemistry Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?
Current Drug Targets Anti-Selectin Therapy for the Treatment of Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Cerebral White Matter Injuries Following a Hypoxic/Ischemic Insult During the Perinatal Period: Pathophysiology, Prognostic Factors, and Future Strategy of Treatment Approach. A Minireview
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Nutritional Programming of Foetal Development: Endocrine Mediators and Long-Term Outcomes for Cardiovascular Health
Current Nutrition & Food Science Anti-Angiogenic Drugs in the Treatment of Metastatic Renal Cell Carcinoma: Advances in Clinical Application
Current Vascular Pharmacology The Autocrine/Paracrine Loop After Myocardial Stretch: Mineralocorticoid Receptor Activation
Current Cardiology Reviews